Mizuho raised its price target on Robinhood Markets (HOOD) from $60 to $65, while analysts maintained their Outperform rating ...

Mizuho Securities analyst Salim Syed maintained a Buy rating on Biogen (BIIB – Research Report) yesterday and set a price target of $207.00.

Japan’s leading financial services group is likely to sign a definite agreement in a month to buy around 80% stake in Avendus ...

Shares of First Solar Inc. (FSLR) gained nearly 1.5% in morning trade on Tuesday after the analysts at Mizuho hiked their ...

Morgan Stanley advised Musk on the purchase, led the financing and sales and also held the largest chunk of X debt. Other ...

Mizuho Securities analyst Gregg Moskowitz maintained a Buy rating on Salesforce (CRM – Research Report) today and set a price target of ...

Genpact (NYSE:G – Get Free Report) had its target price hoisted by analysts at Mizuho from $45.00 to $55.00 in a research ...

Utz Brands (NYSE:UTZ – Get Free Report) had its target price cut by analysts at Mizuho from $21.00 to $19.00 in a research ...

Securities USA LLC, a significant stakeholder in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK), has recently sold a substantial portion of its holdings in the company. The stock, currently trading ...

First Solar upgrade at Mizuho, citing a materially improved sales outlook after 2026 and a stronger competitive position in the U.S. market.

Investing.com -- Mizuho (NYSE: MFG) Securities lifted its rating on First Solar (NASDAQ: FSLR) stock to Outperform from ...